drugset / Trial / NCT00933868

Magnesium Chloride Versus Placebo in Patients Who Have Had a Stroke

NCT00933868

Phase 2/3 Completed 81 enrolled Relox Medical, LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of six intravenous (IV) infusions of magnesium chloride versus placebo in patients who have residual muscle weakness from a stroke that occurred three months to four years ago.

Timeline

Start
2009-04
Primary completion
2010-05
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject MAGNESIUM CHLORIDE ANHYDROUS Small molecule Intravenous

Indications